In addition, to the best of our knowledge, m6A-related AKR1B10 in cancer has not been reported; therefore, our study provides the first evidence that the tumor-promoting function of METTL3 is dependent on the m6A modification of AKR1B10. Here, AKR1B10 is linked to neoplasm.